Repository logo
  • English
  • 中文
  • Log In
    New user? Click here to register.Have you forgotten your password?
Repository logo
    Communities & Collections
    Research Outputs
    Fundings & Projects
    People
    Organizations
    Statistics
  • English
  • 中文
  • Log In
    New user? Click here to register.Have you forgotten your password?
  1. Home
  2. .TMU Publications / 北醫出版品(教師升等著作 / 教學實踐 / 學位論文)
  3. .博碩士學位論文
  4. 109學年度
  5. 思覺失調症患者使用長效針劑與口服抗精神病藥物之效益評估
 
  • Details
Options

思覺失調症患者使用長效針劑與口服抗精神病藥物之效益評估

Other Title
Evaluation of treatment benefit between long-acting injection and oral antipsychotics in patients with schizophrenia
Type
thesis
Date Issued
2021-07-26
Author(s)
陳怡安
Advisor
邵于宣
Subjects
系所名稱:醫學資訊研究所碩士班
Description
學位別:碩士
語文別:中文
指導教授:邵于宣
口試委員:邵于宣 SHAO, YU-HSUAN;方素真 FANG, SU-CHEN;黃名琪 HUANG, MING-CHYI
電子論文連結:https://handle.ncl.edu.tw/11296/586v32
URI
https://203.71.86.71/handle/123456789/61309

Copyright Notice

● The digital content on this platform is part of the Taipei Medical University Institutional Repository, featuring various academic works and outputs from the institution. It offers free access to academic research and public education for non-commercial use.

● Please use the content appropriately and within legal boundaries to respect copyright owners' rights. For commercial use, please obtain prior authorization from the copyright owner. Users must not use TMUIR for any illegal purposes.

● By utilising the platform, users are deemed to have fully accepted and understood all the regulations set out in this statement, relevant laws of the Republic of China, all international internet regulations, and usage conventions.

● TMUIR is committed to protecting the interests of copyright owners. If you believe that any material on this website infringes copyright, please contact our staff at libirtmu@gmail.com, and we will remove the work from the repository.

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Cookie settings
  • Privacy policy
  • End User Agreement
  • Send Feedback